Diagnos Inc Cash Flow Conversion Efficiency
Diagnos Inc cash flow conversion efficiency. Based on the latest financial reports, Diagnos Inc (ADK) has a cash flow conversion efficiency ratio of 0.539x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-828.10K ≈ $-599.04K USD) by net assets (CA$-1.54 Million ≈ $-1.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Diagnos Inc (2002–2025)
Cash flow conversion efficiency of Diagnos Inc from 2002 to 2025. This chart illustrates how Diagnos Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Diagnos Inc for real-time trading data and today's change.
Diagnos Inc Cash Flow Conversion Ratio Explained
Diagnos Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Diagnos Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Diagnos Inc ranked by their cash flow conversion efficiency. Also see market cap of Diagnos Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Caspar
WAR:CSR
|
0.049x |
|
Aquarius Engines AM Ltd
TA:AQUA
|
-32.231x |
|
SP Systems Co.Ltd
KQ:317830
|
0.010x |
|
NDFOS Co. Ltd
KQ:238090
|
-0.005x |
|
BOA Resources Ltd
AU:BOA
|
-0.227x |
|
Phenom Resources Corp
V:PHNM
|
-0.007x |
|
Hidropar Hareket Kontrol Teknolojileri Merkezi Sanayi ve Ticaret A.S.
IS:HKTM
|
-0.323x |
|
OSK Ventures International Bhd
KLSE:0053
|
-0.013x |
Annual Cash Flow Conversion Efficiency for Diagnos Inc (2002–2025)
The table below shows the annual cash flow conversion efficiency of Diagnos Inc from 2002 to 2025. Review ADK free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | CA$233.11K ≈ $168.63K |
CA$-3.64 Million ≈ $-2.63 Million |
-15.604x | -2076.03% |
| 2024-03-31 | CA$-3.05 Million ≈ $-2.21 Million |
CA$-2.41 Million ≈ $-1.74 Million |
0.790x | -18.33% |
| 2023-03-31 | CA$-1.95 Million ≈ $-1.41 Million |
CA$-1.88 Million ≈ $-1.36 Million |
0.967x | -94.61% |
| 2022-03-31 | CA$-113.51K ≈ $-82.11K |
CA$-2.04 Million ≈ $-1.47 Million |
17.954x | +1598.12% |
| 2021-03-31 | CA$1.13 Million ≈ $818.98K |
CA$-1.36 Million ≈ $-981.49K |
-1.198x | +17.44% |
| 2020-03-31 | CA$1.82 Million ≈ $1.32 Million |
CA$-2.64 Million ≈ $-1.91 Million |
-1.452x | -418.05% |
| 2019-03-31 | CA$-5.08 Million ≈ $-3.68 Million |
CA$-2.32 Million ≈ $-1.68 Million |
0.456x | -26.02% |
| 2018-03-31 | CA$-3.64 Million ≈ $-2.63 Million |
CA$-2.24 Million ≈ $-1.62 Million |
0.617x | +92.48% |
| 2017-03-31 | CA$-5.58 Million ≈ $-4.03 Million |
CA$-1.79 Million ≈ $-1.29 Million |
0.321x | -54.80% |
| 2016-03-31 | CA$-3.15 Million ≈ $-2.28 Million |
CA$-2.23 Million ≈ $-1.62 Million |
0.709x | -94.44% |
| 2015-03-31 | CA$-224.85K ≈ $-162.65K |
CA$-2.87 Million ≈ $-2.07 Million |
12.748x | +464.40% |
| 2014-03-31 | CA$346.95K ≈ $250.98K |
CA$-1.21 Million ≈ $-878.01K |
-3.498x | -204.12% |
| 2013-03-31 | CA$1.75 Million ≈ $1.26 Million |
CA$-2.01 Million ≈ $-1.45 Million |
-1.150x | -41.39% |
| 2012-03-31 | CA$2.34 Million ≈ $1.70 Million |
CA$-1.91 Million ≈ $-1.38 Million |
-0.814x | +31.73% |
| 2011-03-31 | CA$1.18 Million ≈ $855.17K |
CA$-1.41 Million ≈ $-1.02 Million |
-1.192x | -56.73% |
| 2010-03-31 | CA$1.98 Million ≈ $1.43 Million |
CA$-1.51 Million ≈ $-1.09 Million |
-0.760x | -4.87% |
| 2009-03-31 | CA$2.41 Million ≈ $1.74 Million |
CA$-1.75 Million ≈ $-1.26 Million |
-0.725x | -557420.15% |
| 2008-03-31 | CA$4.21 Million ≈ $3.04 Million |
CA$-547.00 ≈ $-395.69 |
0.000x | +99.98% |
| 2007-03-31 | CA$1.42 Million ≈ $1.03 Million |
CA$-876.30K ≈ $-633.90K |
-0.616x | +60.42% |
| 2006-03-31 | CA$793.68K ≈ $574.14K |
CA$-1.24 Million ≈ $-894.18K |
-1.557x | +86.16% |
| 2005-03-31 | CA$161.61K ≈ $116.91K |
CA$-1.82 Million ≈ $-1.32 Million |
-11.252x | -1503.98% |
| 2004-03-31 | CA$-128.75K ≈ $-93.14K |
CA$-103.19K ≈ $-74.64K |
0.801x | -73.66% |
| 2003-03-31 | CA$-264.64K ≈ $-191.44K |
CA$-805.06K ≈ $-582.37K |
3.042x | -56.40% |
| 2002-03-31 | CA$-325.75K ≈ $-235.64K |
CA$-2.27 Million ≈ $-1.64 Million |
6.978x | -- |
About Diagnos Inc
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and patho… Read more